Härmark L - Search Results

1

Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.

Oosterhuis I, Taavola H, Tregunno PM, Mas P, Gama S, Newbould V, Caster O, Härmark L. Oosterhuis I, et al. Among authors: harmark l. Drug Saf. 2018 Oct;41(10):969-978. doi: 10.1007/s40264-018-0679-6. Drug Saf. 2018. PMID: 29761281 Free PMC article.

2

Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.

Härmark L, van Hunsel F, Hak E, van Grootheest K. Härmark L, et al. Vaccine. 2011 Feb 24;29(10):1941-7. doi: 10.1016/j.vaccine.2010.12.123. Epub 2011 Jan 12. Vaccine. 2011. PMID: 21236235 Free article.

3

Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information.

Härmark L, van Puijenbroek E, Straus S, van Grootheest K. Härmark L, et al. Drug Saf. 2011 Mar 1;34(3):221-31. doi: 10.2165/11585030-000000000-00000. Drug Saf. 2011. PMID: 21332246

4

Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalin.

Härmark L, Puijenbroek E, Grootheest K. Härmark L, et al. Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):591-7. doi: 10.1002/pds.2135. Pharmacoepidemiol Drug Saf. 2011. PMID: 21538671

5

Web-based intensive monitoring: from passive to active drug surveillance.

Härmark L, van Grootheest K. Härmark L, et al. Expert Opin Drug Saf. 2012 Jan;11(1):45-51. doi: 10.1517/14740338.2012.629184. Epub 2011 Oct 18. Expert Opin Drug Saf. 2012. PMID: 22007719 Review.

6

Experiences with adverse drug reaction reporting by patients: an 11-country survey.

van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. van Hunsel F, et al. Among authors: harmark l. Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000. Drug Saf. 2012. PMID: 22149419 Review.

7

Patients' motives for participating in active post-marketing surveillance.

Härmark L, Lie-Kwie M, Berm L, de Gier H, van Grootheest K. Härmark L, et al. Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):70-6. doi: 10.1002/pds.3327. Epub 2012 Jul 27. Pharmacoepidemiol Drug Saf. 2013. PMID: 22836782

8

Representativeness of diabetes patients participating in a web-based adverse drug reaction monitoring system.

Härmark L, Alberts S, van Puijenbroek E, Denig P, van Grootheest K. Härmark L, et al. Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):250-5. doi: 10.1002/pds.3341. Epub 2012 Aug 30. Pharmacoepidemiol Drug Saf. 2013. PMID: 22933342

9

Experiences with the use of varenicline in daily practice in the Netherlands: a prospective, observational cohort study.

Oosterhuis I, Härmark L, van Puijenbroek E. Oosterhuis I, et al. Among authors: harmark l. Drug Saf. 2014 Jun;37(6):449-57. doi: 10.1007/s40264-014-0166-7. Drug Saf. 2014. PMID: 24817484

10

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.

Härmark L, van Hunsel F, Grundmark B. Härmark L, et al. Drug Saf. 2015 Apr;38(4):337-47. doi: 10.1007/s40264-015-0264-1. Drug Saf. 2015. PMID: 25627832 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters